EVQLV Company

Leveraging advances in computation to revolutionize the design and development of therapeutic antibodies
Technology: Artificial Intelligence, Biotechnology, Health Care, Life Science, Machine Learning, Pharmaceutical
Industry: Early Drug Development
Headquarters: New York, New York, United States
Founded Date: 2019-12-15
Employees Number: 1-10
Funding Status: Seed
Investors Number: 6
Total Funding: 360000
Last Funding Date: 2023-02-13
Last Funding Type: Grant

Visit Website
info@evqlv.com
https://twitter.com/EVQLV_AI
Register and Claim Ownership